30.06.2014 Views

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CHAPTER 1 PRINCIPLES OF CLINICAL PHARMACOLOGY<br />

● Premature termination because of apparent control<br />

of the disease or the presence of adverse effects.<br />

Factors influencing the thoroughness of compliance<br />

include the following.<br />

● Disease being treated<br />

– Seriousness and chronicity<br />

– Natural history and susceptibility to treatment<br />

– Rapidity of relapse once medication is<br />

stopped<br />

● Client<br />

– Degree of commitment to the wellbeing of the<br />

companion animal<br />

– Language skills and ability to understand the<br />

importance of compliance<br />

– Complexity of daily schedule<br />

– Respect for and trust in the veterinarian<br />

● Patient (dog or cat)<br />

– Acceptance or rejection of medications; brachycephalic<br />

breeds and cats may pose particular challenges<br />

to oral medication. Palatable dosage forms<br />

may improve compliance<br />

● Veterinarian<br />

– Strength of relationship with client<br />

– Ability to communicate with, motivate and<br />

provide encouragement of client<br />

● Medication<br />

– Physical form (taste, odor, size) and ease of<br />

administration<br />

– Frequency of administration<br />

– Propensity for side effects<br />

– Influence on the disease being treated, whether<br />

specific, supportive, symptomatic or palliative<br />

– Rapidity of onset of improvement<br />

Compliance can be positively influenced by the following<br />

factors.<br />

● Clinician/client communication. Clinicians should<br />

tailor their style of communication to the client and<br />

ensure full understanding of the disease being treated,<br />

the prognosis, the expected response to treatment<br />

and the nature of any expected side effects, as well<br />

as the circumstances that warrant reassessment.<br />

Interactive development of a mutually agreeable<br />

therapeutic plan with achievable expectations is most<br />

likely to succeed. The clinician should provide an<br />

environment in which the client feels comfortable<br />

about raising any concerns or objections.<br />

● Written instructions. Provide precise, simple but<br />

thorough and legible instructions, which may include<br />

a treatment calendar.<br />

● Medication. Select a medication with physical characteristics<br />

suitable to the skills of the client and<br />

acceptable to the patient. Demonstration of administration<br />

technique and observation of the competence<br />

of the client in administration will allow<br />

appropriate training or adjustment of the plan to be<br />

instituted.<br />

● Dosage regimen. Frequency of dosage and duration<br />

of therapy should be as simple as efficacy, safety and<br />

cost considerations permit. The most sophisticated<br />

treatment regimen is destined to fail if it cannot be<br />

translated into a plan that can be implemented by<br />

the client.<br />

● Follow-up. At the appropriate time, it can be important<br />

to contact the client and assess whether the<br />

therapeutic plan is operating as expected.<br />

Undesirable consequences of poor compliance include:<br />

● inadequate response to treatment, depriving the<br />

patient and client of potential benefits<br />

● recurrence or relapse of the poorly treated<br />

condition<br />

● increased costs caused by continuing need for<br />

reassessment and further treatment<br />

● creation of doubt in the mind of the client and the<br />

clinician about the effectiveness of the drug<br />

● possible use of an elevated dose rate that increases<br />

the likelihood of an adverse effect if compliance is<br />

restored<br />

● underdosing which, in addition to being ineffective,<br />

may be a strong selection force for antibiotic,<br />

arthropod or helminth resistance.<br />

Whenever there is unexpected lack of efficacy or an<br />

adverse response, the investigation should include an<br />

examination of the likelihood of deficient compliance.<br />

A number of studies have shown that owner compliance<br />

cannot be readily predicted by the prescribing<br />

veterinarian.<br />

Medical and medication errors<br />

It has been estimated that the human toll due to medical<br />

management errors exceeds the combined number of<br />

deaths and injuries from motor vehicle and air crashes,<br />

suicides, falls, poisoning and drowning. While there are<br />

a number of important differences between medical and<br />

veterinary practice, it should be expected that errors are<br />

not uncommon in the veterinary arena. Though half the<br />

errors in two large medical studies were related to surgical<br />

procedures, complications arising from drug administration<br />

were the next largest category.<br />

The psychology of human error has been a fruitful<br />

field for psychologists, who have described a combination<br />

of active failures and latent conditions frequently<br />

associated with breaches in safeguards leading to adverse<br />

events.<br />

Active failures can be divided into mistakes, slips and<br />

lapses. Mistakes can result from cognitive errors (e.g.<br />

failing to verify the existence of a sign of disease) or<br />

rule-based errors, incorrectly applying a good rule (oral<br />

14

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!